BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20220057)

  • 1. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.
    Kowluru RA
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4320-6. PubMed ID: 20220057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.
    Kowluru RA; Kanwar M
    Free Radic Biol Med; 2009 Jun; 46(12):1677-85. PubMed ID: 19345729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
    Mishra M; Flaga J; Kowluru RA
    J Cell Physiol; 2016 Aug; 231(8):1709-18. PubMed ID: 26599598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.
    Kowluru RA; Mohammad G; dos Santos JM; Zhong Q
    Diabetes; 2011 Nov; 60(11):3023-33. PubMed ID: 21933988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy.
    Kowluru RA; Atasi L; Ho YS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1594-9. PubMed ID: 16565397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9.
    Mohammad G; Kowluru RA
    J Cell Physiol; 2012 Mar; 227(3):1052-61. PubMed ID: 21567393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats.
    Kowluru RA; Kowluru A; Chakrabarti S; Khan Z
    Diabetes; 2004 Mar; 53(3):775-83. PubMed ID: 14988264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
    Yang R; Liu H; Williams I; Chaqour B
    Ann N Y Acad Sci; 2007 Apr; 1103():196-201. PubMed ID: 17332085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.
    Zhong Q; Kowluru RA
    Diabetes; 2013 Jul; 62(7):2559-68. PubMed ID: 23423566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation of H-Ras and its implications in the development of diabetic retinopathy.
    Kowluru RA; Kanwar M
    Biochem Biophys Res Commun; 2009 Sep; 387(3):461-6. PubMed ID: 19607814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy.
    Kowluru RA; Shan Y; Mishra M
    Lab Invest; 2016 Oct; 96(10):1040-9. PubMed ID: 27454437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.
    Santos JM; Tewari S; Lin JY; Kowluru RA
    Biochem Biophys Res Commun; 2013 Sep; 438(4):760-4. PubMed ID: 23891690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina.
    Kowluru V; Kowluru RA
    Mol Vis; 2007 Apr; 13():602-10. PubMed ID: 17515880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
    Xu X; Zhu Q; Xia X; Zhang S; Gu Q; Luo D
    Curr Eye Res; 2004 Apr; 28(4):251-6. PubMed ID: 15259294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
    Duraisamy AJ; Mishra M; Kowluru RA
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.
    Kowluru RA; Shan Y
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):955-962. PubMed ID: 28124145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy.
    Kanwar M; Kowluru RA
    Microvasc Res; 2008 Nov; 76(3):189-93. PubMed ID: 18514235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy.
    Kowluru RA; Koppolu P
    Free Radic Res; 2002 Sep; 36(9):993-9. PubMed ID: 12448825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha.
    Zheng Z; Chen H; Wang H; Ke B; Zheng B; Li Q; Li P; Su L; Gu Q; Xu X
    Diabetes; 2010 Sep; 59(9):2315-25. PubMed ID: 20566666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.
    Zhang W; Yan H
    Exp Eye Res; 2012 Dec; 105():1-8. PubMed ID: 23059402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.